By Michele Maatouk
Date: Monday 17 Jun 2019
(Sharecast News) - Shares in cancer drug developer Array Biopharma rocketed on Monday after it agreed to be bought by Pfizer in a deal worth $11.4bn.
No recent information was found.
Currency | US Dollars |
Share Price | $ 9.07 |
Change Today | $ 0.68 |
% Change | 8.10 % |
52 Week High | $9.07 |
52 Week Low | $4.23 |
Volume | 6,919,596 |
Shares Issued | 211.67m |
Market Cap | $1,919.81m |
RiskGrade | 281 |
Time | Volume / Share Price |
16:00 | 504,990 @ $9.07 |
15:59 | 100 @ $9.07 |
15:59 | 100 @ $9.07 |
15:59 | 100 @ $9.07 |
15:59 | 100 @ $9.07 |
You are here: research